Hydrogen Mitigated Doxorubicin-Induced Liver Injury via Nrf2/HO-1 Pathway Activation
International Journal of Molecular Sciences · 19.03.2026 · 27 (6) · 2774
DOI: 10.3390/ijms27062774 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.03.2026. Verfasst von Meng-Fan Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Technology Innovation Center of TCM Combined Hydrogen Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, China. Hauptthemen laut MEDLINE: Doxorubicin, NF-E2-Related Factor 2, Chemical and Drug Induced Liver Injury, Hydrogen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province medical science research project.
Abstract (Originalsprache)
Drug-induced liver injury constitutes a major concern within the spectrum of drug-related pathologies. The precise mechanisms underlying doxorubicin (DOX)-induced liver injury remain inadequately elucidated. Hydrogen is known for its selective antioxidant properties and favorable safety profile; however, its protective effects against DOX-induced liver injury have not been fully clarified. In this study, a model of DOX-induced liver injury was established to evaluate hepatic function and pathological alteration, thereby assessing the therapeutic efficacy of hydrogen. Further investigations were conducted to quantify oxidative stress and inflammatory markers to elucidate the potential mechanisms involved. Hydrogen treatment significantly mitigated DOX-induced liver damage and inhibited hepatocyte fibrosis. Hydrogen was found to suppress apoptosis, reduce oxidative stress levels, and ameliorate inflammatory responses in the liver tissue of DOX mice. The protective effect was predominantly facilitated by the modulation of the Nrf2/HO-1 pathway. Importantly, the hepatoprotective effect of hydrogen was negated following the administration of an Nrf2 inhibitor in HepG2 cells. These results suggest that hydrogen may mitigate DOX-induced liver injury by activating the Nrf2/HO-1 signaling pathway, consequently diminishing oxidative stress and inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei Technology Innovation Center of TCM Combined Hydrogen Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
- Transformation Center for Scientific and Technological Achievements, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
- School of Nursing, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
ORCID-Profile: Meng-Fan Sun, Ya-Shuo Zhao
Förderung
- Hebei Province medical science research project
Zitieren
APA
Sun, M. F., Song, J. X., Tang, M., Yu, B. H., Xiao, Y., Gao, Y. H., Yao, Z. X., An, K. Y., Zhang, Z. Q., Shen, Y. Q., & Zhao, Y. S. (2026). Hydrogen Mitigated Doxorubicin-Induced Liver Injury via Nrf2/HO-1 Pathway Activation. International Journal of Molecular Sciences, 27(6), 2774. https://doi.org/10.3390/ijms27062774
Vancouver
Sun MF, Song JX, Tang M, Yu BH, Xiao Y, Gao YH, et al. Hydrogen Mitigated Doxorubicin-Induced Liver Injury via Nrf2/HO-1 Pathway Activation. International Journal of Molecular Sciences. 2026;27(6):2774. doi:10.3390/ijms27062774
BibTeX
@article{Sun2026,
author = {Sun, Meng-Fan and Song, Ji-Xian and Tang, Miao and Yu, Bo-Han and Xiao, Yao and Gao, Yu-Hui and Yao, Zi-Xuan and An, Ke-Ying and Zhang, Zhen-Qun and Shen, Yong-Qing and Zhao, Ya-Shuo},
title = {Hydrogen Mitigated Doxorubicin-Induced Liver Injury via Nrf2/HO-1 Pathway Activation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2774},
doi = {10.3390/ijms27062774}
}
EUVIMED